The Largest Personal Injury Firm in Texas. Serving Clients Nationwide.
Austin 512-520-0221 Corpus Christi 361-254-7873 San Antonio 210-874-2615 Nationwide Toll Free 866-517-5659
Contact us 24/7 Contact us 24/7

Our attorneys and staff continue to work through COVID-19 and remain available 24/7, ready to fight for you. Our video conferencing, case management, and telecommunications systems allow us to stay in constant contact with our clients and pursue their claims without interruption – all without our clients leaving the comfort of their homes. You focus on staying healthy and safe, we’re here to handle the rest.

FDA Approves J&J Diabetes Drug Invokana Despite Risks

susan_harr7 years ago

Johnson & Johnson’s Janssen Pharmaceuticals Unit has received FDA approval for its new diabetes drug, Invokana (canagliflozin). The drug is the first in a new class of Type 2 Diabetes meds dubbed SGLT2 inhibitors; drugs in this class work by reducing the amount of sugar absorbed in the body and flushing any excess out through the urine.

Invokana has the potential to offer an innovative means to battle the disease (which affects approx. 26 million Americans) but also showed serious risks, including heart attack and stroke, in clinical trial patients.

Risks Linked to J&J’s New Diabetes Drug- Invokana

According to several published reports, Invokana reportedly caused a variety of side effects in clinical trial patients, including:

  • Elevated stroke risk (within the first 30 days)
  • Increase in heart attack risk (within the first 30 days)
  • Drops in blood pressure
  • Rise in LDL cholesterol levels
  • Urinary tract infections (UTIs) and yeast infections

FDA Orders Additional Studies on Invokana

According to the FDA, Janssen is required to complete 5 post marketing studies on Invokana, including:

  • A cardiovascular outcomes trial;
  • A bone safety study;
  • Two pediatric safety studies;
  • And an enhanced pharmacovigilance program to monitor for:
    • malignancies
    • serious cases of pancreatitis
    • severe hypersensitivity reactions
    • photosensitivity reactions
    • liver abnormalities
    • adverse pregnancy outcomes
Contact an Experienced Product Liability Attorney

Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.

If you or a loved one have been injured by or have developed serious side-effects from the use of defective medications or medical devices, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.


Contact Us for a FREE Case Review

866-517-5659 •

Do you really want to end conversation?
chat-icon Live chat
avatar Waiting